{
 "name": "吉晟生",
 "slug": "tw-7762",
 "aliases": [
  "吉晟生技股份有限公司",
  "PET PHARM BIO",
  "7762"
 ],
 "ticker": "7762",
 "industry": "生技醫療業",
 "website": "https://www.petpharmbio.com",
 "summary": "吉晟生（7762）是興櫃的生技醫療類股公司，2011 年成立，2024 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "吉晟生技股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "PET PHARM BIO",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2024-07-25",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2011-10-03",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "楊朝堂",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "林亮光",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 580913340,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "安侯建業聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.petpharmbio.com",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "主要產品：18F-FDG（氟去氧葡萄糖注射劑）",
   "value": "評估葡萄糖代謝，以及癌症診斷、分期和治療監測之正子造影藥物",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "114年度年報；PDF封面刊印日115年4月30日。完整核准日期未揭露，未新增產品許可fact。"
  },
  {
   "claim": "主要產品：18F-FBB（腦立晰NeuraCeq）",
   "value": "供認知功能障礙成人接受阿茲海默症等評估時，估計腦中β型澱粉樣蛋白神經炎斑塊密度",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "114年度年報；PDF封面刊印日115年4月30日。完整核准日期未揭露，未新增產品許可fact。"
  },
  {
   "claim": "主要產品：18F-NaF（氟化鈉注射劑）",
   "value": "偵測全身骨骼活性區域變化之正子造影藥物",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "114年度年報；PDF封面刊印日115年4月30日。完整核准日期未揭露，未新增產品許可fact。"
  },
  {
   "claim": "主要產品：131I（碘化鈉膠囊）",
   "value": "甲狀腺癌診斷追蹤及放射性治療用藥物",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "114年度年報；PDF封面刊印日115年4月30日。完整核准日期未揭露，未新增產品許可fact。"
  },
  {
   "claim": "管線：161Tb-PSMA I&T",
   "value": "前列腺癌｜已取得TFDA臨床試驗許可｜台灣",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "年報致股東報告書；未在此來源確認NCT編號及完整試驗開始日。"
  },
  {
   "claim": "管線：18F-FBPA",
   "value": "BNCT治療配套檢驗造影｜一期／二期臨床試驗許可已取得｜台灣",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "年報PDF第9頁；CDMO合作項目，非已取得上市藥證。"
  },
  {
   "claim": "管線：177Lu-PSMA I&T",
   "value": "晚期前列腺癌｜取得專案製造許可並投入臨床供藥｜台灣",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "年報PDF第53頁（內頁49）177Lu-PSMA I&T段落；專案製造不等於藥品上市許可。"
  },
  {
   "claim": "管線：AV-133（帕金森氏症造影）",
   "value": "帕金森氏症造影｜藥品製造與臨床試驗合作（期別未揭露）｜地區未揭露",
   "unit": "",
   "as_of": "2026-04-30",
   "source": "https://petpharmbio.com/userfiles/files/annual%20report/2025_7762_Annual_Report.pdf",
   "note": "年報PDF第6頁；合作對象位於美國不代表試驗地區已公開，未代填試驗期別或地區。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-7762.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}